Clinical trial
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women…
NCT00398437 · Jules Bordet Institute, Other · Unknown status
Key facts
| NCT number | NCT00398437 |
|---|---|
| Title | Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer |
| Official title | Role of Gadolinium Enhanced Brain Magnetic Resonance in the Follow Up of Metastatic Breast Cancer Patients Overexpressing HER2 Neu. A Randomized Prospective Study |
| Lead sponsor | Jules Bordet Institute, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | trastuzumab, chemotherapy, magnetic resonance imaging |
| Enrollment | 96 |
| Start date | Sep 1, 2006 |
| First posted | Nov 10, 2006 |
| Last update posted | Aug 12, 2013 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: